Skip to main content

Table 1 Comparison of clinical data between DR and Control groups

From: Circular RNA circZNF532 facilitates angiogenesis and inflammation in diabetic retinopathy via regulating miR-1243/CARM1 axis

Characteristics

Control (n = 23)

DR(n = 23)

P value

Gender (Male/female)

15/8

16/7

0.55

Age (years)

51.52 ± 6.2

50.38 ± 5.8

0.62

BMI (kg/m2)

28.3 ± 3.6

25.9 ± 5.2

0.01*

Smoking history

0.09

 No

18

16

 

 Yes

5

7

 

HbA1c (%)

3.86 ± 0.41

8.96 ± 2.33

0.04*

Family history of DM

0.42

 No

15

16

 

 Yes

8

7

 

BP systolic, mm Hg

103.5 ± 6.98

118.4 ± 14.21

0.03*

BP diastolic, mm Hg

63.2 ± 8.99

75.23 ± 10.15

0.02*

TG (mmol/L)

1.38 ± 0.21

1.53 ± 0.18

0.63

TC (mmol/L)

4.02 ± 0.47

4.36 ± 0.48

0.06

HDL (mg/dL)

58.31 ± 11.96

50.12 ± 12.31

0.03*

LDL (mg/dL)

126.25 ± 21.21

136.33 ± 12.89

0.06

Urinary creatinine, mmol/L

9.62 ± 5.11

11.32 ± 4.52

0.46

FPG (mmol/L)

5.03 ± 0.85

7.62 ± 0.38

0.02*

FINS (mIU/I)

5.36 ± 0.68

5.52 ± 0.77

0.51

  1. BMI, body mass index; HbA1c, haemoglobin A1c; DM, diabetes mellitus; DR, diabetic retinopathy; BP, blood pressure; TG, triacylglycerol; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low density lipoprotein; FPG, fasting plasma glucose; FINS, fasting insulin
  2. *P < 0.05